[ Price : $8.95]
Human Genome Sciences and its development partner, Novartis, decide not to further develop Zalbin (albinterferon alfa-2b) after re...[ Price : $8.95]
A Domain Incite report says FDA may be preparing to take stronger action to shut down Internet domain names of pharmacies illegall...[ Price : $8.95]
FDA grants Prolor Biotech an orphan drug designation for hGH-CTP, a long-acting human growth hormone.[ Price : $8.95]
FDA grants Aeterna Zentaris an orphan drug designation for Solorel (macimorelin) and its use as an oral diagnostic test for adult ...[ Price : $8.95]
CDRH publishes for comment a list of 42 guidances it is considering developing in 2011.[ Price : $8.95]
Industry commenters on an FDA draft guidance on reportable post-manufacturing changes say FDA should consolidate its CMC reporting...[ Price : $8.95]
Jazz Pharmaceuticals says FDA has indicated that an ANDA has been submitted for a generic version of its narcolepsy drug Xyrem.[ Price : $8.95]
Federal Register Notice: FDA submits a proposed collection of information on export of FDA-regulated products and export certifica...